248 related articles for article (PubMed ID: 31103677)
1. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
Xu J; Ge Y; Bu R; Zhang A; Feng S; Wang J; Gou J; Yin T; He H; Zhang Y; Tang X
J Control Release; 2019 Jul; 305():18-28. PubMed ID: 31103677
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
Yang H; Zhang F; Fan Y; Zhang J; Fang T; Xing D; Zhen Y; Nie Z; Liu Y; Wang D; Li J
Pharm Res; 2024 Mar; 41(3):531-546. PubMed ID: 38366235
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
[TBL] [Abstract][Full Text] [Related]
5. Extended drug delivery by contact lenses for glaucoma therapy.
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
[TBL] [Abstract][Full Text] [Related]
6. Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.
Desai AR; Maulvi FA; Desai DM; Shukla MR; Ranch KM; Vyas BA; Shah SA; Sandeman S; Shah DO
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110885. PubMed ID: 32409042
[TBL] [Abstract][Full Text] [Related]
7. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
[TBL] [Abstract][Full Text] [Related]
8. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
Hsu KH; Carbia BE; Plummer C; Chauhan A
Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
[TBL] [Abstract][Full Text] [Related]
9. A promising 'single' and 'dual' drug-nanocomposite enriched contact lens for the management of glaucoma in response to the tear fluid enzyme.
Kumara BN; Velmurugan K; Ghate MV; Shambhu R; Nirmal J; Prasad KS
J Mater Chem B; 2024 Feb; 12(9):2394-2412. PubMed ID: 38349383
[TBL] [Abstract][Full Text] [Related]
10. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
[TBL] [Abstract][Full Text] [Related]
11. A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma.
Zhao J; Xiong J; Ning Y; Zhao J; Wang Z; Long L; He H; Gou J; Yin T; Tang X; Zhang Y
Eur J Pharm Biopharm; 2023 Apr; 185():44-54. PubMed ID: 36841507
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.
Fechtner RD; Airaksinen PJ; Getson AJ; Lines CR; Adamsons IA;
Acta Ophthalmol Scand; 2004 Feb; 82(1):42-8. PubMed ID: 14982045
[TBL] [Abstract][Full Text] [Related]
13. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
Maeda-Chubachi T; Chi-Burris K; Simons BD; Freedman SF; Khaw PT; Wirostko B; Yan E;
Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022
[TBL] [Abstract][Full Text] [Related]
14. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
Nordmann JP; Söderström M; Rouland JF; Malecaze F
Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
[TBL] [Abstract][Full Text] [Related]
17. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
J Control Release; 2013 Jan; 165(1):82-9. PubMed ID: 23123188
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of latanoprost versus travoprost assessed by daily intraocular pressure curve].
Santos HD; Fernandes TA; Souza CA; Cronemberger S; Calixto N
Arq Bras Oftalmol; 2009; 72(1):13-7. PubMed ID: 19347115
[TBL] [Abstract][Full Text] [Related]
19. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
20. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
